Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45


Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy.

Jackson WG, Oromendia C, Unlu O, Erkan D, DeSancho MT; Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking.

Blood Adv. 2017 Nov 16;1(25):2320-2324. doi: 10.1182/bloodadvances.2017008185. eCollection 2017 Nov 28.


Complete Resolution of a Large Bicuspid Aortic Valve Thrombus with Anticoagulation in Primary Antiphospholipid Syndrome.

Rachwan RJ, Daher GE, Fares J, Rachoin R.

Front Cardiovasc Med. 2017 Sep 20;4:59. doi: 10.3389/fcvm.2017.00059. eCollection 2017.


Diagnosis and management of the antiphospholipid syndrome.

Chaturvedi S, McCrae KR.

Blood Rev. 2017 Nov;31(6):406-417. doi: 10.1016/j.blre.2017.07.006. Epub 2017 Jul 30. Review.


Bilateral Superficial Femoral Artery Thrombosis in a 15-Year-Old Caucasian Male with Homozygous Prothrombin G20210A Genotype and Associated Antiphospholipid Syndrome.

Yoon U, Kwok L, Flessenkaemper I.

Int J Angiol. 2016 Dec;25(5):e100-e105. doi: 10.1055/s-0035-1548557. Epub 2015 Mar 23.


Role of Novel Oral Anticoagulants in the Treatment of Antiphospholipid Syndrome.

White CW, Thomason AR, Boyd K.

Hosp Pharm. 2016 Oct;51(9):759-767.


Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.

Cohen H, Hunt BJ, Efthymiou M, Arachchillage DR, Mackie IJ, Clawson S, Sylvestre Y, Machin SJ, Bertolaccini ML, Ruiz-Castellano M, Muirhead N, Doré CJ, Khamashta M, Isenberg DA; RAPS trial investigators.

Lancet Haematol. 2016 Sep;3(9):e426-36. doi: 10.1016/S2352-3026(16)30079-5.


Warfarin Dosing and Time Required to Reach Therapeutic International Normalized Ratio in Patients with Hypercoagulable Conditions.

Kahlon P, Nabi S, Arshad A, Jabbar A, Haythem A.

Turk J Haematol. 2016 Dec 1;33(4):299-303. doi: 10.4274/tjh.2015.0271. Epub 2016 Apr 18.


Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives.

Magro-Checa C, Zirkzee EJ, Huizinga TW, Steup-Beekman GM.

Drugs. 2016 Mar;76(4):459-83. doi: 10.1007/s40265-015-0534-3. Review.


Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism.

Witt DM, Clark NP, Kaatz S, Schnurr T, Ansell JE.

J Thromb Thrombolysis. 2016 Jan;41(1):187-205. doi: 10.1007/s11239-015-1319-y. Review.


The antiphospholipid syndrome: still an enigma.

Chaturvedi S, McCrae KR.

Hematology Am Soc Hematol Educ Program. 2015;2015:53-60. doi: 10.1182/asheducation-2015.1.53. Review.


Sarcoidosis and Antiphospholipid Syndrome: A Systematic Review of Cases.

Pathak R, Khanal R, Aryal MR, Giri S, Karmacharya P, Pathak B, Acharya U, Bhatt VR.

N Am J Med Sci. 2015 Sep;7(9):379-83. doi: 10.4103/1947-2714.166213. Review.


Therapeutic challenges after successful thrombectomy in a patient with an antiphospholipid syndrome associated M1-occlusion: A case report.

Stadler K, Mutzenbach JS, Kalss G, Sellner J, Al-Schameri AR, Trinka E, Killer-Oberpfalzer M.

Interv Neuroradiol. 2015 Oct;21(5):598-602. doi: 10.1177/1591019915590371. Epub 2015 Jul 1.


Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches.

Chighizola CB, Ubiali T, Meroni PL.

J Immunol Res. 2015;2015:951424. doi: 10.1155/2015/951424. Epub 2015 May 5. Review.


Treatment of the antiphospholipid syndrome.

Galli M.

Auto Immun Highlights. 2013 Dec 22;5(1):1-7. doi: 10.1007/s13317-013-0056-5. eCollection 2014 Jun. Review.


Management of the antiphospholipid syndrome.

Espinosa G, Cervera R.

Auto Immun Highlights. 2010 Jul 10;1(1):15-22. doi: 10.1007/s13317-010-0004-6. eCollection 2010 May. Review.


Multiple thromboses in a patient with systemic lupus erythematosus after splenectomy.

Yang DH.

Case Reports Immunol. 2012;2012:813629. doi: 10.1155/2012/813629. Epub 2012 May 28.


Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.

Cohen H, Doré CJ, Clawson S, Hunt BJ, Isenberg D, Khamashta M, Muirhead N; RAPS Trial Protocol Collaborators.

Lupus. 2015 Sep;24(10):1087-94. doi: 10.1177/0961203315581207. Epub 2015 May 4.


Implant surgery and oral anticoagulant therapy: case report.

Miranda M, Bollero P, D'Ovidio N, Marsango V, Barlattani A Jr.

Oral Implantol (Rome). 2014 Dec 27;7(2):51-6. eCollection 2014 Apr-Jun.


A case of antiphospholipid syndrome refractory to secondary anticoagulating prophylaxis after deep vein thrombosis-pulmonary embolism.

Gu KM, Shin JW, Park IW.

Tuberc Respir Dis (Seoul). 2014 Dec;77(6):274-8. doi: 10.4046/trd.2014.77.6.274. Epub 2014 Dec 31.

Supplemental Content

Support Center